KELLY STRATEGIC CRISPR & GENE EDITING TECHNOLOGY ETF - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.38 USD | -1.60% |
|
-2.45% | -25.75% |
Composition of Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
|---|---|---|---|---|---|---|
| 564.6 USD | +1.33% | -1.30% | +6.37% | 11.69% | ||
| 24.22 USD | +0.29% | -3.70% | -20.56% | 11.15% | ||
| 56.24 USD | -5.64% | -11.52% | -10.16% | 8.55% | ||
| 22.94 USD | -0.43% | -7.76% | -15.72% | 8.03% | ||
| 1.72 USD | 0.00% | -3.91% | -69.98% | 6.97% | ||
| 2.78 USD | +4.91% | +0.72% | -17.26% | 4.87% | ||
| 5.11 USD | +1.39% | +0.99% | -49.56% | 4.83% | ||
| 170.4 USD | -1.01% | +1.07% | +9.95% | 4.81% | ||
| 5.99 USD | -2.60% | -15.75% | -32.39% | 4.71% | ||
| 5.29 USD | +3.12% | -2.40% | -62.05% | 4.13% | ||
| 95.4 CHF | +1.50% | +2.12% | +12.55% | 3.79% | ||
| 0.4448 USD | -1.27% | -11.06% | -18.13% | 3.66% | ||
| 2.55 USD | +4.51% | +8.51% | -20.56% | 3.54% | ||
| 133.2 USD | +0.39% | +2.62% | -4.16% | 2.57% | ||
| 41.93 USD | +2.17% | +1.77% | -18.28% | 2.37% | ||
| 3.72 USD | -1.06% | -5.82% | -12.88% | 2.23% | ||
| 89.46 EUR | +2.10% | +2.03% | -0.35% | 2.20% | ||
| 108.6 USD | +0.30% | -0.08% | -22.03% | 1.77% | ||
| 468.7 USD | -0.57% | -2.50% | +15.19% | 1.71% | ||
| 1,053 USD | +0.84% | +1.60% | +19.91% | 1.62% | ||
| 224 USD | -0.70% | -3.32% | -13.44% | 0.65% | ||
Description
| US48817R7061 | |
|---|---|
| Total Expense Ratio | 0.78% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Strategic CRISPR & Gene Editing Technology Index NR - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
11/01/2022
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/10/2023 )
| AuM (EUR) | 2 M€ |
|---|---|
| AuM 1M | 2 M€ |
| AuM 3 months | 2 M€ |
| AuM 6 months | 2 M€ |
| AuM 12 months | 5 M€ |
- Stock Market
- ETF
- XDNA ETF
- Components Kelly Strategic CRISPR & Gene Editing Technology ETF - USD
